PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 63 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8,680,000 | +1082.6% | 310,000 | +1348.6% | 0.00% | – |
Q4 2021 | $734,000 | +90.6% | 21,400 | -1.9% | 0.00% | – |
Q3 2021 | $385,000 | -86.5% | 21,805 | -66.1% | 0.00% | -100.0% |
Q2 2021 | $2,844,000 | +18.3% | 64,280 | -28.6% | 0.00% | -50.0% |
Q1 2021 | $2,404,000 | -12.7% | 90,073 | -32.6% | 0.00% | 0.0% |
Q4 2020 | $2,755,000 | +9083.3% | 133,574 | +9407.0% | 0.00% | – |
Q3 2020 | $30,000 | -6.2% | 1,405 | -22.2% | 0.00% | – |
Q2 2020 | $32,000 | +700.0% | 1,805 | +196.4% | 0.00% | – |
Q1 2020 | $4,000 | -78.9% | 609 | -78.2% | 0.00% | – |
Q4 2019 | $19,000 | -24.0% | 2,794 | +35.0% | 0.00% | – |
Q3 2019 | $25,000 | -26.5% | 2,070 | -26.7% | 0.00% | – |
Q2 2019 | $34,000 | -75.5% | 2,823 | -74.4% | 0.00% | – |
Q1 2019 | $139,000 | +3375.0% | 11,026 | +1675.5% | 0.00% | – |
Q4 2018 | $4,000 | -33.3% | 621 | +0.5% | 0.00% | – |
Q3 2018 | $6,000 | +50.0% | 618 | +1.5% | 0.00% | – |
Q2 2018 | $4,000 | -60.0% | 609 | -45.8% | 0.00% | – |
Q1 2018 | $10,000 | -91.9% | 1,123 | -81.1% | 0.00% | – |
Q4 2017 | $123,000 | +1266.7% | 5,930 | +1086.0% | 0.00% | – |
Q3 2017 | $9,000 | +50.0% | 500 | -4.6% | 0.00% | – |
Q2 2017 | $6,000 | – | 524 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |